GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Liabilities-to-Assets

Cessatech AS (XSAT:CESSA) Liabilities-to-Assets : 0.05 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Cessatech AS's Total Liabilities for the quarter that ended in Mar. 2024 was kr1.01 Mil. Cessatech AS's Total Assets for the quarter that ended in Mar. 2024 was kr19.92 Mil. Therefore, Cessatech AS's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 0.05.


Cessatech AS Liabilities-to-Assets Historical Data

The historical data trend for Cessatech AS's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Liabilities-to-Assets Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
0.01 0.14 0.15 1.23

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.24 0.34 1.23 0.05

Competitive Comparison of Cessatech AS's Liabilities-to-Assets

For the Biotechnology subindustry, Cessatech AS's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cessatech AS's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Cessatech AS's Liabilities-to-Assets falls into.



Cessatech AS Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Cessatech AS's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=10.423/8.504
=1.23

Cessatech AS's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as

Liabilities-to-Assets (Q: Mar. 2024 )=Total Liabilities/Total Assets
=1.012/19.921
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cessatech AS  (XSAT:CESSA) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Cessatech AS Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cessatech AS (XSAT:CESSA) Business Description

Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS (XSAT:CESSA) Headlines

No Headlines